• 1
    Warkentin TE. Heparin-induced thrombocytopenia: a clinicopathologic syndrome. Thromb Haemost 1999; 82: 43947.
  • 2
    Amiral J, Marfaing-Koka A. Poncz M. Meyer D. The biological basis of immune heparin-induced thrombocytopenia. Platelets 1998; 9: 7791.
  • 3
    Polgar J, Eichler P, Greinacher A, Clemetson KJ. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients. Blood 1998; 91: 54954.
  • 4
    Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse B, Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 1999; 111: 7006.
  • 5
    Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-thrombocytopenia. Blood 1986; 67: 2730.
  • 6
    Greinacher A, Alban S, Dummel V, Franz G, Mueller-Eckardt C. Characterization of the structural requirements for a carbohydrate-based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia. Thromb Haemost 1995; 74: 88692.
  • 7
    Herbert JM, Hérault LP, Bernat A, Savi P, Schaeffer P, Driguez PA, Duchaussoy P, Petitou M. SR123781A, a synthetic heparin mimetic. Thromb Haemost 2001; 85: 85260.
  • 8
    Petitou M, Hérault JP, Bernat A, Driquez PA, Duchaussoy P, Lormeau JC, Herbert JM. Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature 1999; 398: 41722.
  • 9
    Teien AN, Lie M. Evaluation of an amidolytic heparin assay method: increased sensibility by adding purified antithrombin III. Thromb Res 1977; 102: 399410.
  • 10
    Stringer SE, Gallagher JT. Specific binding of the chemokine platelet factor 4 to heparan sulfate. J Biol Chem 1994; 272: 2050814.
  • 11
    Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Meth 1995; 184: 3951.
  • 12
    Thiagarajan P, Tait JF. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 1991; 266: 243027.
  • 13
    Israels SJ, Gerrard JM, Jacques YV, McNicol A, Cham B, Nishibori M, Bainton DF. Platelet dense granule membranes contain both granulophysin and P-selectin (GMP-140). Blood 1992; 80: 14352.
  • 14
    Rand ML, Perry DW, Packham MA, Gemmell CH, Yeo EL, Kinlough-Rathbone RL. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN. Direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression. Am J Hematol 1996; 52: 28894.
  • 15
    Shattil SJ, Brass LF. Induction of the fibrinogen receptor on human platelets by intracellular mediators. J Biol Chem 1987; 262: 9921000.
  • 16
    Savi P, Zamboni G, Rescanieres O, Herbert JM. Studies on the binding of 3H-SR121566, an inhibitor of Gp IIb-IIIa activation. Thromb Haemost 2001; 85: 7029.
  • 17
    Savi P, Heilmann E, Nurden P, Laplace MC, Bihour C, Kieffer G, Nurden AT, Herbert JM. Clopidogrel. an antithrombotic drug acting on the ADP-dependent activation pathway of human platelets. Clin Appl Thromb Hemostas 1996; 2: 3542.
  • 18
    Harenberg J, Huhle G, Giese C, Wang LC, Feuring M, Song XH, Hoffmann U. Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 2000; 109: 1826.